Please provide us with a few details so that we can match you with the right expert in your field.
*Required
Our ADMET and DMPK services streamline your drug discovery process by enabling rapid, accurate, and compound-efficient assays. With validated screening services and in vivo PK support, we ensure your programs progress swiftly and effectively.
The impact of absorption, distribution, metabolism, excretion and toxicity (ADMET) properties can dramatically and negatively impact otherwise good drug activity. Conducting ADMET & DMPK studies early in the drug discovery process can minimize compound failure by:
Later in development, ADMET and DMPK studies help validate toxicology studies, support safety evaluations prior to First-in-Human (FIH) and indicate the likelihood of drug-drug interactions.
Our ADMET & DMPK team emphasizes the value of time and resource at project initiation to accelerate design, make, test cycles and help make informed decisions.
We are well-positioned to meet the needs of our client’s whether they require rapid data turnaround from routine screens, or customized assays for challenging molecules.